Promising results for extended-release buprenorphine

A study has shown high treatment retention and adherence, reduced substance use and depression, and improved quality of life among those receiving monthly BUP-XR Community use of long-acting buprenorphine has shown positive findings after two years of follow up, according to Professor Michael Farrell, Director of the National Drug and Alcohol Research Centre (NDARC) at

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Is texting an effective smoking cessation tool?
Next Technology gods byte